
Food and drink giant Nestlé has confirmed it is in motion to scoop up the remaining shares in Californian biotech …

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …

It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …

Following the recent revelation that Pfizer was considering the spin-out of its consumer health division, it has now emerged that …

Nestle Health Science has invested $145 million in return for a 15% stake in Aimmune Therapeutics. Aimmune pursues food-allergy therapies …

The announcement of Paul Navarre’s appointed as CEO of Nestlé Skin Health was announced on 11 October. He will take …

Pfizer has said it is setting up a new standalone company out of its animal health division. This means it …

Pfizer has sold its nutrition business to Nestlé for $11.85 billion in cash. Pfizer Nutrition is a leading global pediatric …
Nestlé is to take on conditions such as diabetes, obesity, cardiovascular disease and Alzheimer’s with the creation of two research …

A new report says the market for personalised medicine products is set to grow strongly over the next few years, …